ACADIA Pharmaceuticals Inc. - stock earnings
ACAD Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | 45.8 million USD | 231.0 million USD |
| 2023Q3 | -65.2 million USD | 211.7 million USD |
| 2023Q2 | 1.1 million USD | 165.2 million USD |
| 2023Q1 | -43.0 million USD | 118.5 million USD |
| 2022Q4 | -41.7 million USD | 136.5 million USD |
| 2022Q3 | -27.2 million USD | 130.7 million USD |
| 2022Q2 | -34.0 million USD | 134.6 million USD |
| 2022Q1 | -113.1 million USD | 115.5 million USD |
| 2021Q4 | -43.1 million USD | 130.8 million USD |
| 2021Q3 | -14.5 million USD | 131.6 million USD |
| 2021Q2 | -43.9 million USD | 115.2 million USD |
| 2021Q1 | -66.4 million USD | 106.6 million USD |
| 2020Q4 | -66.8 million USD | 121.0 million USD |
| 2020Q3 | -84.7 million USD | 120.6 million USD |
| 2020Q2 | -42.1 million USD | 110.1 million USD |
| 2020Q1 | -88.0 million USD | 90.1 million USD |
| 2019Q4 | -53.0 million USD | 98.3 million USD |
| 2019Q3 | -42.0 million USD | 94.6 million USD |
| 2019Q2 | -54.9 million USD | 83.2 million USD |
| 2019Q1 | -85.3 million USD | 63.0 million USD |
| 2018Q4 | -65.5 million USD | 59.6 million USD |
| 2018Q3 | -62.1 million USD | 58.3 million USD |
| 2018Q2 | -63.3 million USD | 57.1 million USD |
| 2018Q1 | -54.3 million USD | 48.9 million USD |
| 2017Q4 | -68.9 million USD | 43.6 million USD |
| 2017Q3 | -65.2 million USD | 35.6 million USD |
| 2017Q2 | -67.4 million USD | 30.5 million USD |
| 2017Q1 | -87.8 million USD | 15.3 million USD |
| 2016Q4 | -78.7 million USD | 12.0 million USD |
| 2016Q3 | -71.6 million USD | 5.3 million USD |
| 2016Q2 | -71.3 million USD | 97000 USD |
| 2016Q1 | -49.8 million USD | 4000 USD |
| 2015Q4 | -45.8 million USD | 17000 USD |
| 2015Q3 | -38.9 million USD | 39000 USD |
| 2015Q2 | -39.4 million USD | 1000 USD |
| 2015Q1 | -40.4 million USD | 4000 USD |
| 2014Q4 | -28.4 million USD | 47000 USD |
| 2014Q3 | -24.8 million USD | 15000 USD |
| 2014Q2 | -21.5 million USD | 28000 USD |
| 2014Q1 | -17.8 million USD | 30000 USD |
| 2013Q4 | -12.0 million USD | 37000 USD |
| 2013Q3 | -10.7 million USD | 240000 USD |
| 2013Q2 | -9.1 million USD | 451000 USD |
| 2013Q1 | -6.1 million USD | 417000 USD |
| 2012Q4 | -6.8 million USD | 380000 USD |
| 2012Q3 | -2.4 million USD | 3.5 million USD |
| 2012Q2 | -5.4 million USD | 599000 USD |
| 2012Q1 | -6.2 million USD | 450000 USD |
| 2011Q4 | -5.3 million USD | 588000 USD |
| 2011Q3 | -5.1 million USD | 584000 USD |
| 2011Q2 | -6.6 million USD | 460000 USD |
| 2011Q1 | -5.8 million USD | 435000 USD |
| 2010Q4 | 29.1 million USD | 35.4 million USD |
| 2010Q3 | -4.2 million USD | 2.3 million USD |
| 2010Q2 | -4.3 million USD | 2.3 million USD |
| 2010Q1 | -5.5 million USD | 2.1 million USD |
| 2009Q4 | -8.7 million USD | 1.8 million USD |
| 2009Q3 | -8.7 million USD | 2.4 million USD |
| 2009Q2 | -12.7 million USD | 1.8 million USD |
| 2009Q1 | -15.0 million USD | 374000 USD |
| 2008Q4 | -14.0 million USD | 325000 USD |
| 2008Q3 | -15.6 million USD | 282000 USD |
| 2008Q2 | -18.3 million USD | 177000 USD |
| 2008Q1 | -16.4 million USD | 806000 USD |
| 2007Q4 | -17.0 million USD | 1.6 million USD |
| 2007Q3 | -16.0 million USD | 2.0 million USD |
| 2007Q2 | -10.8 million USD | 2.1 million USD |
| 2007Q1 | -12.6 million USD | 2.0 million USD |
| 2006Q4 | -12.5 million USD | 1.8 million USD |
| 2006Q3 | -11.3 million USD | 1.9 million USD |
| 2006Q2 | -11.9 million USD | 1.9 million USD |
| 2006Q1 | -9.5 million USD | 2.5 million USD |
| 2005Q4 | -10.2 million USD | 2.4 million USD |
| 2005Q3 | -12.3 million USD | 3.7 million USD |
| 2005Q2 | -6.0 million USD | 2.5 million USD |
| 2005Q1 | -5.6 million USD | 2.3 million USD |
| 2004Q4 | -7.3 million USD | 1.1 million USD |
| 2004Q3 | -6.2 million USD | 1.6 million USD |
| 2004Q2 | -5.9 million USD | 1.0 million USD |
| 2004Q1 | -6.5 million USD | 923900 USD |
| 2003Q4 | -3.5 million USD | 1.8 million USD |
| 2003Q3 | -3.5 million USD | 1.8 million USD |
| 2003Q2 | -3.0 million USD | 2.3 million USD |
| 2003Q1 | -3.4 million USD | 1.8 million USD |
| 2002Q4 | ? USD | 6.3 million USD |
ACAD Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -61.3 million USD | 726.4 million USD |
| 2022 | -216.0 million USD | 517.2 million USD |
| 2021 | -167.9 million USD | 484.1 million USD |
| 2020 | -281.6 million USD | 441.8 million USD |
| 2019 | -235.3 million USD | 339.1 million USD |
| 2018 | -245.2 million USD | 223.8 million USD |
| 2017 | -289.4 million USD | 124.9 million USD |
| 2016 | -271.4 million USD | 17.3 million USD |
| 2015 | -164.4 million USD | 61000 USD |
| 2014 | -92.5 million USD | 120000 USD |
| 2013 | -37.9 million USD | 1.1 million USD |
| 2012 | -20.8 million USD | 4.9 million USD |
| 2011 | -22.8 million USD | 2.1 million USD |
| 2010 | 15.1 million USD | 42.1 million USD |
| 2009 | -45.1 million USD | 6.4 million USD |
| 2008 | -64.2 million USD | 1.6 million USD |
| 2007 | -56.4 million USD | 7.6 million USD |
| 2006 | -45.0 million USD | 8.1 million USD |
| 2005 | -34.1 million USD | 11.0 million USD |
| 2004 | -25.9 million USD | 4.6 million USD |
| 2003 | -14.1 million USD | 7.4 million USD |
| 2002 | -12.9 million USD | 6.3 million USD |
| 2001 | -14.4 million USD | 3.7 million USD |
| 2000 | -10.2 million USD | 4.3 million USD |
ACAD
Price: $17.05
52 week price:
Earnings Per Share: -0.37 USD
P/E Ratio: -27.67
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 1.4 million
Ebitda: -65.6 millionMarket Capitalization: 2.9 billion